Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 66.0
(-1.35%)
TWD 66.0
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -26.87 Million | -21.65 Million | -6.34 Million | - |
| Net Income | -34.93 Million | -21.81 Million | -8.43 Million | - |
| Depreciation & Amortization | 1.91 Million | 1.62 Million | 638 Thousand | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 7 Million | -312 Thousand | 1.45 Million | - |
| Other non-cash items | -20.05 Million | -8.16 Million | -193 Thousand | - |
| Investing Cash Flow | -243.26 Million | -714.77 Million | -84.23 Million | - |
| Investments in PPE | -662 Thousand | -2.77 Million | -2.95 Million | - |
| Acquisitions | - | - | - | - |
| Investment purchases | -242 Million | -712 Million | -81 Million | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -602 Thousand | -714.3 Million | -284 Thousand | - |
| Financing Cash Flow | -991 Thousand | 284.6 Million | 915.56 Million | - |
| Debt repayment | -991 Thousand | -991 Thousand | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | 285.6 Million | 916 Million | - |
| Other Financing Activities | -991 Thousand | 285.6 Million | 1.22 Billion | - |
| Accounts receivables | -10 Million | - | - | - |
| Accounts payables | 2.85 Million | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 14.15 Million | -312 Thousand | -142.66 Thousand | - |
| Cash at beginning of period | 373.15 Million | 824.98 Million | - | - |
| Cash at end of period | 102.02 Million | 373.15 Million | 824.98 Million | - |
| Capital Expenditure | -662 Thousand | -2.77 Million | -2.95 Million | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -271.13 Million | -451.82 Million | 824.98 Million | - |
| Free Cash Flow | -27.54 Million | -24.43 Million | -9.29 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.22 Million | -23.22 Million | -12.18 Million | -34.93 Million | -12.18 Million | -6.39 Million |
| Depreciation & Amortization | 553.5 Thousand | 553.5 Thousand | 424 Thousand | 1.91 Million | 424 Thousand | 419 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.6 Million | 2.34 Million | 2.11 Million | 7 Million | 2.11 Million | -42 Thousand |
| Other non-cash items | -985.5 Thousand | -1.73 Million | 1.46 Million | -20.05 Million | 1.46 Million | 759.5 Thousand |
| Investing Cash Flow | -7.5 Million | -7.5 Million | -121.61 Million | -243.26 Million | -121.61 Million | -21 Thousand |
| Investments in PPE | - | - | -17 Thousand | -662 Thousand | -17 Thousand | -17 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -35 Million | - | - | -242 Million | - | - |
| Sales/Maturities of investments | 20 Million | - | - | - | - | - |
| Other Investing Activities | -7.5 Million | -7.5 Million | -121.59 Million | -602 Thousand | -121.59 Million | -4000.00 |
| Financing Cash Flow | -323 Thousand | -323 Thousand | -225 Thousand | -991 Thousand | -225 Thousand | -270.5 Thousand |
| Debt repayment | -200 Thousand | - | - | -991 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -323 Thousand | -323 Thousand | -225 Thousand | - | -225 Thousand | -270.5 Thousand |
| Accounts receivables | 5 Million | 5 Million | -5 Million | -10 Million | -5 Million | - |
| Accounts payables | -2.85 Million | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.4 Million | -2.65 Million | 7.11 Million | 14.15 Million | 7.11 Million | -42 Thousand |
| Cash at beginning of period | 102.02 Million | - | - | 373.15 Million | - | - |
| Cash at end of period | -29.88 Million | -29.88 Million | -130.01 Million | 102.02 Million | -130.01 Million | -5.55 Million |
| Capital Expenditure | - | - | -17 Thousand | -662 Thousand | -17 Thousand | -17 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -131.9 Million | -29.88 Million | -130.01 Million | -271.13 Million | -130.01 Million | -5.55 Million |
| Free Cash Flow | -22.06 Million | -22.06 Million | -8.19 Million | -27.54 Million | -8.19 Million | -5.27 Million |
2898
688013
0090
002819
4741
6708